-
Wuhan Guanggu humanwell class 1.1 analgesic meisuoshuli obtained clinical approval
Time of Update: 2020-04-03
Humanwell pharmaceutical announced in the evening of June 23 that the company's joint-stock subsidiary, Wuhan Optics Valley humanwell, had obtained the clinical approval documents for the 1.1-class ch
-
Guizhou Province plans to lay out a blueprint for the development of new pharmaceutical industry
Time of Update: 2020-04-03
As a "sister chapter", the new pharmaceutical industry must have the same strength, level and effect as the big data industry This is the consensus reached at the new pharmaceutical industry developme
-
Production approval of 6 kinds of cefmetazole sodium APIs for Fuan pharmaceutical industry
Time of Update: 2020-04-03
Fuan Pharmaceutical Co., Ltd announced in the evening of the 26th that the company's six kinds of chemical drugs "Cefmetazole sodium" APIs have recently been received from the State Food and Drug Admi
-
Four projects in Guizhou Province are supported by the fourth batch of subprojects in the 12th Five Year Plan of the major national science and technology project of "major new drug creation"
Time of Update: 2020-04-03
Recently, four projects in Guizhou Province have been supported by the fourth batch of subprojects of the 12th Five Year Plan, a major science and technology project of "major new drug creation", with
-
Zhongzhu holding's acquisition of xintaidayi in a new anticancer drug recombinant human endostatin adenovirus injection
Time of Update: 2020-04-03
Zhongzhu holding, which has been suspended for three weeks, announced on the evening of January 23 that it intends to acquire 70% of the equity of Guangzhou new TEDA Biotechnology Co., Ltd., as well a
-
7-year review long run after the approved production of Zhifei biological AC Hib triple vaccine
Time of Update: 2020-04-03
The AC Hib triple vaccine independently developed by Beijing green bamboo, a wholly-owned subsidiary of Zhifei biology, was finally approved for production after a seven-year review run It is reported
-
The project of "industrialization of new anesthetic drugs hydromorphone hydrochloride and alfentanil" of humanwell pharmaceutical has obtained the state subsidy of 50 million yuan
Time of Update: 2020-04-03
Humanwell announced in the evening of April 2 that four ministries and commissions of the state planned to arrange a state subsidy of 50 million yuan for the company's "industrialization of new narcot
-
Phase III study of hpatinib in the treatment of advanced gastric cancer
Time of Update: 2020-04-03
According to Hengrui pharmaceutical company, apatinib's phase III research on the treatment of advanced gastric cancer will make an oral report at the annual meeting of the American Society of Clinica
-
Kunming Pharmaceutical Group 3.2 ferrous fumarate tablets for iron deficiency anemia
Time of Update: 2020-04-03
According to the public information released by the State Food and Drug Administration on April 29, the 3.2-class iron deficiency anemia drug of Kunming Pharmaceutical Co., Ltd., ferrous folic acid fu
-
Two major new drugs, esomeprazole and Utilins, will be launched in this year
Time of Update: 2020-04-03
Qiu Yu, chairman and general manager of Laimei pharmaceutical, said at the online performance exchange meeting that the company is actively promoting the preparations for listing of esomeprazole and U
-
Gefitinib, a Class 3 antitumor drug of Peking University medicine, has been accepted
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on April 15, gefitinib, a Class 3 antitumor drug, applied by Peking University Pharmaceutical Co., Ltd., was accepted At prese
-
Adenosylmethionine succinate, a new hepatobiliary drug from Zhenyuan, Zhejiang Province, has entered the final approval stage
Time of Update: 2020-04-03
This means that the drug has passed the technical review and production site inspection and entered the final approval stage Zhejiang Zhenyuan is expected to obtain the product production approval doc
-
Shutai snake venom class I new drug "clotting factor X activator for injection" is expected to enter the second phase of clinical practice this year
Time of Update: 2020-04-03
Shutai Shenzhong new drug "clotting factor X activator for injection" is in the second phase of clinical application, and is expected to enter the second phase of clinical application this year "Clott
-
Guizhou bailing anti hepatitis a new drug tifentai Y101 obtained clinical approval
Time of Update: 2020-04-03
Tefentai tablet is a kind of new chemical medicine against hepatitis B, and it is a major new drug creation project in the 12th Five Year Plan, Guizhou bailing has undertaken a total of 30 million yua
-
[in depth inventory] up to now, there are only 10 kinds of domestic monoclonal antibodies approved by CFDA for listing
Time of Update: 2020-04-03
In 1986, OKT3, the world's first monoclonal antibody drug for the treatment of rejection in organ transplantation, was approved by the US FDA, which started the development of monoclonal antibody drug
-
Silitan, a new antihypertensive drug of xinlitai, plans to carry out overseas registration and clinical work
Time of Update: 2020-04-03
Xinlitai (Ye Yuxiang, general manager, said at the performance briefing today that the company's new product, xinlitan (alisartan ester tablets), is a global innovative product At present, it has obta
-
Sichuan chuanshegan flavone capsule and Ranjiangduoji capsule obtained the production approval
Time of Update: 2020-04-03
Recently, chuanshegan flavone capsule and Ranjiangduoji capsule, two kinds of traditional Chinese medicine, have been approved by the State Administration, breaking through the situation that no new t
-
Approved production of Zhifei biological typhoid Vi polysaccharide vaccine
Time of Update: 2020-04-03
According to the information on June 18 on the website of the State Food and Drug Administration (CFDA), the production approval of typhoid Vi polysaccharide vaccine declared by Beijing green bamboo b
-
New drug research and development progress disclosed by Northeast Pharmaceutical
Time of Update: 2020-04-03
Zhang Zhengwei, financial director of Northeast Pharmaceutical, stressed in the dingzeng roadshow that the company is now gradually completing the transformation from API to pharmaceutical industry ch
-
The unveiling ceremony of the State Key Laboratory of innovative drugs and efficient energy saving pharmaceutical equipment was held in Jiangzhong group
Time of Update: 2020-04-03
On the morning of November 28, the unveiling ceremony of the State Key Laboratory of innovative drugs and efficient energy saving and consumption reducing pharmaceutical equipment was held in Jiangzho
